We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Large-Scale European Project Initiated for Imaging in Stem Cell Therapy Research

By Biotechdaily staff writers
Posted on 24 Jun 2008
An international research group from 10 countries is planning to develop imaging technologies and methods in the field of cell therapy.

The European Institute for Biomedical Imaging Research (EIBIR; Vienna, Austria) has taken over the coordination of a European large-scale research project. More...
The project, entitled ENCITE (European Network for Cell Imaging and Tracking Expertise), began on June 1, 2008.

Currently, there is no single imaging modality that meets the requirements of stem cell therapy. However, magnetic resonance imaging (MRI) has huge potential in this regard. Moreover, other imaging methods, particularly optical imaging, will be considered in the course of the project. Within the framework of the project, new MRI imaging techniques and biomarkers will be developed and evaluated to get a more comprehensive outlook of cell fate and the reaction of the immune system. Ultimately, these are planned to be applied in the treatment of cancer, cardiovascular diseases and diabetes.

The project is supported by a financial contribution of EUR 11 million within the European Commission's seventh Framework Program. EIBIR was founded in January 2006 and is a nonprofit organization with more than 200 member institutions from 27 countries. As the project develops, further highly qualified partners will be needed to contribute either research or dissemination and training activities for the newly developed methods. In order to find these partners, a Competitive Call will be launched in the project ENCITE in autumn 2008.


Related Links:
European Institute for Biomedical Imaging Research

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.